A study of correlation between clinical profile of patients with non- alcoholic fatty liver disease and individual components of metabolic syndrome at a tertiary care centre in Uttarakhand region: an observational cross-sectional study

Authors

  • Rishabh Aggarwal Department of Internal Medicine, AIIMS Rishikesh, Uttarakhand, India
  • Monika Pathania Department of Internal Medicine, AIIMS Rishikesh, Uttarakhand, India
  • Rohit Raina Department of Internal Medicine, AIIMS Rishikesh, Uttarakhand, India
  • Amritpal Singh Department of Internal Medicine, AIIMS Rishikesh, Uttarakhand, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20232670

Keywords:

Lifestyle modification, Metabolic syndrome, Non-alcoholic fatty liver disease

Abstract

Background: Research indicates that the occurrence of non-alcoholic fatty liver disease (NAFLD) in India is reported to range from approximately 9% to 32%. This study aims to examine the clinical characteristics of subjects diagnosed with NAFLD and investigate the association between NAFLD and individual components of metabolic syndrome.

Methods: This was a cross-sectional, hospital-based study, conducted over a period of 2 months from May 2017 to June 2017 in patients attending medicine OPD or admitted in IPD in AIIMS Rishikesh. Study population included sonologicaly diagnosed cases of NAFLD of age group 18 to 70 years. Patients with a history of jaundice, positive viral markers for hepatitis C or hepatitis B, pregnant women, individuals who consume alcohol, and patients with a history of hepatotoxic drug consumption were excluded.

Results: A total of 40 NAFLD cases, as confirmed ultrasonographically, were included in the study. Out of all the patients diagnosed with NAFLD, 26 (65%) were found to have metabolic syndrome based on the NCEP ATP III criteria. Upon investigating the correlation between NAFLD and individual components of metabolic syndrome, a significant association (p<0.05) was observed with BMI, waist circumference, systolic and diastolic blood pressure, as well as serum triglyceride levels.

Conclusions: Uttarakhand being hilly region mainly, it is expected that lifestyle will be healthy due to cultural and environmental factors, but rapid urbanisation has led to change in lifestyle which needs to be addressed in the population of this Himalayan state.

References

National Drug Dependence Treatment Center, Alcohol web India: Useful tips for lower-risk drinking (2016). Available from https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed 14 July 2017.

Gaharwar R, Trikha S, Margekar SL, Jatav OP, Ganga PD. Study of clinical profile of patients of non alcoholic fatty liver disease and its association with metabolic syndrome. J Assoc Phys India. 2015;63(1):12-6.

Duseja A. Nonalcoholic fatty liver disease in India–a lot done, yet more required!. Ind J Gastroenterol. 2010;29:217-25.

Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, et al. Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Experi Hepatol. 2015;5(1):51-68.

Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. WJG. 20142;20(7):1724.

Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13(1):9.

Abdel Malek MF. Non-alcoholic fatty liver disesaes and non-alcoholic steatohepatitis. In: Kasper L, Fauci S.(eds.) Harrison’s principles of internal medicine 19th edition. New York: Mc Graw Hill; 2015:2054-2057.

Marchesini G, Brizi M, Bianchi G. Nonalcoholic fatty liver disease a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844-50.

Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221–31.

Steering Committee of the Western Pacific region of the World Health Organization. The International Association for the study of Obesity and the International Study Task Force. The Asia Pacific perspective; redefining obesity and its treatment. Health Communications, Australia. 2000:8-56.

Duseja A, Das A, Kiran KT, Dhiman RK, Chawla Y, Das R et al. Clinicopathological profile of Indian patients with non-alcoholic fatty liver disease is different from that in the west. Dig Dis Sci. 2007;52:2368-74.

Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovas Dis Res. 2012;3(3):204-11.

Deb A, Chattopadhyay A, Hassan K, Bhattacharya J, Basu M. Clinical profile of patients with nonalcoholic fatty liver disease and its association with metabolic syndrome: a cross-sectional study. IOSR J Dent Med Sci (IOSR-JDMS). 2015;14(12):11-5.

Uchil D, Pipalia D, Chawla M, Patel R, Maniar S, Narayani, Juneja A. Non-alcoholic fatty liver disease (NAFLD)-the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009;57:201-4.

Sanyal AJ. AGA technical review on non-alcoholic fatty liver disease. Gastroenterol. 2002;123(5):1705–25.

Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatol. 2003;37(5):1202-19.

Duseja A, Das A, Dhiman RK, Chawla YK, Das R, Bhadada S, et al. Indian patients with non-alcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol. 2007;13(4):649-50.

Madan K, Batra Y, Gupta SD, Chander B, Rajan KA, Tewatia MS, et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. WJG. 2006;12(21):3400.

Amarapurkar DN, Patel ND. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. Trop Gastroenterol. 2004;25(3):125-9.

Barros FD, Setubal S, Martinho JM, Ferraz L, Gaudencio A. Correlation of non-alcoholic fatty liver disease and features of metabolic syndrome in morbidly obese patients in the preoperative assessment for bariatric surgery. Arq Bras Cir Dig. 2016;29(4):260-3.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 17. 2002;106:3143-421.

Roti A, Sunita M, Dixit VK, Sweta R. Association of nonalcoholic fatty liver disorder with obesity. Indian J Prev Soc Med. 2008;39:13-6.

Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, et al. A case-control study on insulin resistance, metabolic covariates & prediction score in non-alcoholic fatty liver disease. Indian J Med Res. 2009;129(3):285-92.

Downloads

Published

2023-08-29

How to Cite

Aggarwal, R., Pathania, M., Raina, R., & Singh, A. (2023). A study of correlation between clinical profile of patients with non- alcoholic fatty liver disease and individual components of metabolic syndrome at a tertiary care centre in Uttarakhand region: an observational cross-sectional study. International Journal Of Community Medicine And Public Health, 10(9), 3143–3149. https://doi.org/10.18203/2394-6040.ijcmph20232670

Issue

Section

Original Research Articles